Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-222779
Filing Date
2026-05-14
Accepted
2026-05-14 07:18:46
Documents
74
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ivvd-20260331.htm   iXBRL 10-Q 1941820
2 EX-10.6 ivvd-ex10_6.htm EX-10.6 45425
3 EX-10.7 ivvd-ex10_7.htm EX-10.7 35918
4 EX-10.8 ivvd-ex10_8.htm EX-10.8 45212
5 EX-31.1 ivvd-ex31_1.htm EX-31.1 19381
6 EX-32.1 ivvd-ex32_1.htm EX-32.1 11737
  Complete submission text file 0001193125-26-222779.txt   8981829

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ivvd-20260331.xsd EX-101.SCH 1382133
78 EXTRACTED XBRL INSTANCE DOCUMENT ivvd-20260331_htm.xml XML 1531600
Mailing Address 209 CHURCH STREET NEW HAVEN CT 06510
Business Address 209 CHURCH STREET NEW HAVEN CT 06510 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40703 | Film No.: 26975821
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)